Dosimetry comparison between a 3D printed minimally invasive guidance template and free implantation in the brachytherapy treatment of postoperative recurrent cervical carcinoma

References

• Sardain H, Lavoue V, Redpath M, et al. Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy: asystema-tic review. Eur J Surg Oncol. 2015;41(8):975–985. doi:10.1016/j.ejso.2015.03.23525922209
   PubMed Web of Science ®Google Scholar
• Li L, Ma SQ, Tan XJ, et al. Pelvic exenteration for recurrent and persistent cervical cancer. Chin Med J (Engl). 2018;131(13):1541–1548. doi:10.4103/0366-6999.23511129941707
   PubMed Web of Science ®Google Scholar
• Chiantera V, Rossi M, De Iaco P, et al. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. Gynecol Cancer. 2014;24(5):916–922. doi:10.1097/IGC.0b013e3182a80aec
   PubMed Web of Science ®Google Scholar
• Ng MK, Leong T, Heriot AG, et al. Once-daily reirradiation for rectal cancer in patients who have received previous pelvic radiotherapy. Med Imaging Radiat Oncol. 2013;57:512–518. doi:10.1111/1754-9485.12057
   PubMed Web of Science ®Google Scholar
• Sadozye AH, Reed N. A review of recent developments in image-guided radiation therapy in cervix cancer. Curr Oncol Rep. 2012;14(6):519–526. doi:10.1007/s11912-012-0275-322986929
   PubMed Web of Science ®Google Scholar
• Yoshida K, Yamazaki H, Kotsuma T, et al. Treatment results of image-guided high-dose-rate interstitial brachytherapy for pelvic recurrence of uterine cancer. Brachytherapy. 2015;14(4):440–448. doi:10.1016/j.brachy.2015.02.19525858904
   PubMed Web of Science ®Google Scholar
• Mabuchi S, Takahashi R, Isohashi F, et al. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience. Gynecol Cancer. 2014;24(1):141–148. doi:10.1097/IGC.0000000000000028
   PubMed Web of Science ®Google Scholar
• Mahantshetty U, Kalyani N, Engineer R, et al. Reirradiation using high-dose-rate brachytherapy in recurrent carcinoma of uterine cervix. Brachytherapy. 2014;13(6):548–553. doi:10.1016/j.brachy.2014.06.00525085457
   PubMed Web of Science ®Google Scholar
• Takekuma M, Kuji S, Tanaka A, et al. Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer. Gynecol Oncol. 2015;26(3):185–192. doi:10.3802/jgo.2015.26.3.185
   Web of Science ®Google Scholar
• Aoki Y, Ochiai K, Lim S, et al. Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer. Br J Cancer. 2018;119(8):530–537. doi:10.1038/s41416-018-0206-730072745
   PubMedGoogle Scholar
• Liu ZS, Guo J, Zhao YZ, et al. Dosimetric analysis of CT-guided salvage interstitial brachytherapy for recurrent cervical cancer. Chin J Radiat Oncol. 2018;27(1):74–78. doi:10.3760/cma.j.issn.1004-4221.2018.01.015
   Google Scholar
• Haie-Meder C, Potter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group(I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235–245. doi:10.1016/j.radonc.2004,12.01515763303
   PubMed Web of Science ®Google Scholar
• Potter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (II): concepts and terms in 3D image-based 3D treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78(1):67–77. doi:10.1016/j.radonc.2005:11.01416403584
   PubMed Web of Science ®Google Scholar
• Zolciak-Siwinska A, Bijok M, Jonska-Gmyrek J, et al. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk. Gynecol Oncol. 2014;132(1):93–97. doi:10.1016/j.ygyno.2013.10.01824161366
   PubMed Web of Science ®Google Scholar
• Umezawa R, Murakami N, Nakamura S, et al. Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: asingle-institution study. Brachytherapy. 2018;17(2):368–376. doi:10.1016/j.brachy.2017.11.01129275869
   PubMed Web of Science ®Google Scholar
• Kotsuma T, Yoshida K, Yamazaki H, et al. Preliminary results of magnetic resonance imaging-aided high-dose-rate interstitial brachytherapy for recurrent uterine carcinoma after curative surgery. Radiat Res. 2011;52(3):329–334. doi:10.1269/jrr.10172
   Web of Science ®Google Scholar
• Sethi R, Cunha JAN, Mellis K, et al. 3D printed custom applicator for high-dose-rate intracavitary vaginal cuff brachytherapy. Brachytherapy. 2014;13(1):S93. doi:10.1016/j.brachy.2014.02.371
   Google Scholar
• Amsbaugh MJ, Bhatt N, Hunter T, et al. Computed tomography planned interstitial brachytherapy for recurrent gynecologic cancer. Brachytherapy. 2015;14(5):600–605. doi:10.1016/j.brachy.2015.05.00726087868
   PubMed Web of Science ®Google Scholar
• Fokdal L, Tanderup K, Nielsen SK, et al. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. Radiother Oncol. 2011;100(3):473–479. doi:10.1016/j.radonc.2011.08.01621924784
   PubMed Web of Science ®Google Scholar
• Fokdal L, Tanderup K, Hokland SB, et al. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Radiother Oncol. 2013;107(1):63–68. doi:10.1016/j.radonc.2013.01.01023452917
   PubMed Web of Science ®Google Scholar
• Wiebe E, Easton H, Thomas G, et al. Customized vaginal vault brachytherapy with computed tomography imaging-derived applicator prototyping. Brachytherapy. 2015;14(3):380–384. doi:10.1016/j.brachy.2014.12.00625630618
   PubMed Web of Science ®Google Scholar
• Jiang P, Guo FX, Jiang YL, et al. 3D-printing non-coplanar template assisted CT-guided 125I seed implantation on pelvic recurrent cervical cancer. Chin J Radiol Med Pro. 2017;37(7):490–494. doi:10.3760/cma.j.issn.0254-5098.2017.07.003
   Google Scholar
• Jiang YL, Wang H, Ji Z, et al. Computed tomography image-guided and personalized 3D printed template-assisted 125-iodine seed implantation for recurrent pelvic tumor: adosimetric study. Chin J Radiat Oncol. 2016;25(9):959–964. doi:10.3760/cma.j.issn.1004-4221.2016.09.012
   Google Scholar
• Hongtao Z, Xuemin D, Huimin Y, et al. Dosimetry study of three-dimensional print template-guided precision 125I seed implantation. Cancer Res Ther. 2016;12(2):159–165. doi:10.4103/0973-1482.200607
   Google Scholar
• Viswanathan AN, Beriwal S, De Los Santos JF, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy. 2012;11(1):47–52. doi:10.1016/j.brachy.2011.07.00222265437
   PubMed Web of Science ®Google Scholar
• Lewis SC, Mahantshetty U, Enginee R, et al. Reirradiation with high-dose-rate brachytherapy in recurrent cervical cancer - an update. Brachytherapy. 2016;15(1):S91–S91. doi:10.1016/j.brachy.2016.04.148
   Google Scholar